| Jared R Manning, MD | |
|
1281 N 600 E, Logan, UT 84341-6988 | |
| (435) 716-6400 | |
| Not Available |
| Full Name | Jared R Manning |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 19 Years |
| Location | 1281 N 600 E, Logan, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326209701 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Logan Regional Hospital | Logan, UT | Hospital |
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Wood River Medical Center | Ketchum, ID | Hospital |
| Cassia Regional Hospital | Burley, ID | Hospital |
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
Portland State University researchers used advanced electron microscopy to create a 3-D reconstruction of a membrane protein at an unprecedented level of resolution, setting the stage for the development of drugs that could target the protein more effectively to treat a variety of diseases.
United States Navy and NASA researchers have each examined the impact of sleep in individuals living and working underwater but researchers with Clayton Sleep Institute (CSI) in St. Louis are hoping to gain new insight with a study in cooperation with Fabien Cousteau's Mission 31.
RadioIowa reports that Iowa Sen. Chuck Grassley says hospital officials around the country are seeing bugs in new health information technology software that are putting patients at risk. "'Over the last few months, concerns have been brought to my attention including administrative complications, formatting and usability issues, errors in interoperability,' Grassley says. 'Some health care providers have said the software is producing incorrect medication dosages because it miscalculated body weights by interchanging kilograms and pounds.'" Grassley is asking 32 hospitals for statements on the problem (Kelley, 1/19).
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
A retinoid called all-trans retinoic acid (ATRA), which is a vitamin A-derivative, is already used successfully to treat a rare sub-type of acute myeloid leukemia (AML), however this drug has not been effective for the more common types of AMLs.
› Verified 6 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Portland State University researchers used advanced electron microscopy to create a 3-D reconstruction of a membrane protein at an unprecedented level of resolution, setting the stage for the development of drugs that could target the protein more effectively to treat a variety of diseases.
United States Navy and NASA researchers have each examined the impact of sleep in individuals living and working underwater but researchers with Clayton Sleep Institute (CSI) in St. Louis are hoping to gain new insight with a study in cooperation with Fabien Cousteau's Mission 31.
RadioIowa reports that Iowa Sen. Chuck Grassley says hospital officials around the country are seeing bugs in new health information technology software that are putting patients at risk. "'Over the last few months, concerns have been brought to my attention including administrative complications, formatting and usability issues, errors in interoperability,' Grassley says. 'Some health care providers have said the software is producing incorrect medication dosages because it miscalculated body weights by interchanging kilograms and pounds.'" Grassley is asking 32 hospitals for statements on the problem (Kelley, 1/19).
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
A retinoid called all-trans retinoic acid (ATRA), which is a vitamin A-derivative, is already used successfully to treat a rare sub-type of acute myeloid leukemia (AML), however this drug has not been effective for the more common types of AMLs.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jared R Manning, MD Po Box 27128, Salt Lake City, UT 84127-0128 Ph: () - | Jared R Manning, MD 1281 N 600 E, Logan, UT 84341-6988 Ph: (435) 716-6400 |
News Archive
Portland State University researchers used advanced electron microscopy to create a 3-D reconstruction of a membrane protein at an unprecedented level of resolution, setting the stage for the development of drugs that could target the protein more effectively to treat a variety of diseases.
United States Navy and NASA researchers have each examined the impact of sleep in individuals living and working underwater but researchers with Clayton Sleep Institute (CSI) in St. Louis are hoping to gain new insight with a study in cooperation with Fabien Cousteau's Mission 31.
RadioIowa reports that Iowa Sen. Chuck Grassley says hospital officials around the country are seeing bugs in new health information technology software that are putting patients at risk. "'Over the last few months, concerns have been brought to my attention including administrative complications, formatting and usability issues, errors in interoperability,' Grassley says. 'Some health care providers have said the software is producing incorrect medication dosages because it miscalculated body weights by interchanging kilograms and pounds.'" Grassley is asking 32 hospitals for statements on the problem (Kelley, 1/19).
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical trial of its novel eye-drop candidate, INO-8875, in patients with glaucoma or ocular hypertension.
A retinoid called all-trans retinoic acid (ATRA), which is a vitamin A-derivative, is already used successfully to treat a rare sub-type of acute myeloid leukemia (AML), however this drug has not been effective for the more common types of AMLs.
› Verified 6 days ago
Rudolf Otrusinik, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1300 N 500 E, Suite 320, Logan, UT 84341 Phone: 435-755-8200 Fax: 435-752-6094 | |
Harold Vonk, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-1980 | |
Robert M Nash, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1980 | |
Agnieszka M Szpunar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1980 | |
Dr. Stephen J Ferney, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-752-1693 Fax: 435-792-1692 | |
Dr. Stephen Christensen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 W 1250 North Suite 8a, Logan, UT 84341 Phone: 385-244-4020 Fax: 385-244-4022 | |
Ali Ben-jacob, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1281 North 600 East, Logan, UT 84341 Phone: 435-752-5999 Fax: 435-752-5551 |